White willow: benefits, dosage, contraindications

Mis à jour le

The willow is a tree of the Salicaceae family that can reach 25 m in height. It is common in the Northern Hemisphere, across Europe, in North America and in Asia, particularly in wet areas along the banks of waterways. Willow bark was commonly used in Hippocrates' time. Patients were advised to chew the bark to relieve pain and fever. The salicin, a component of willow bark discovered in 1831, acts as a precursor of salicylic acid in the body. In herbal medicine, the dried bark of young twigs must contain at least 1.5% salicylate derivatives, expressed as salicin. Salicylic acid, resulting from the oxidation of salicin, was used from the mid-19th century, but its use was limited because of its irritating effects on the stomach. In 1853, a French chemist modified salicylic acid to create acetylsalicylic acid, but did not pursue its development. In 1897, Felix Hoffmann, a chemist at Bayer, rediscovered this substance in the treatment of rheumatoid arthritis. Two years later, Bayer marketed Aspirin. Since then, it has become one of the most widely used drugs in the world. Contrary to popular belief, aspirin was developed from the salicin of meadowsweet and not from willow bark. Willow bark works in a very similar way to Aspirin. Thus, it is used for pain, notably headaches, muscle or joint pain, menstrual cramps, arthritis, osteoarthritis, gout and more generally for inflammatory rheumatism.

Scientific name(s)

Salix Alba

Family or group: 

Plants

Active ingredients:

Salicin


Indications

Scoring methodology

EFSA approval.

Several randomized, double-blind, controlled clinical trials (> 2), including a significant number of patients (>100), with consistently positive conclusions for the indication.
Several randomized, double-blind, controlled clinical trials (> 2), including a significant number of patients (>100), with positive conclusions for the indication.
One or more randomized studies, or several cohorts or epidemiological studies, with positive conclusions for the indication.
Clinical studies exist but are uncontrolled, with conclusions that may be positive or conflicting.
No clinical studies to date that can demonstrate the indication.


Low back pain
✪✪✪✪✪

It has been shown that daily intake of a willow bark extract providing 120-240 mg of salicin can reduce low back pain in some patients. The higher concentration of 240 mg salicin is more effective than 120 mg salicin. Significant relief may take up to one week. nnSome research suggests that 240 mg of salicin per day is as effective as conventional treatments for low back pain.nnWillow bark extract 393-1600 mg providing 120-240 mg of salicin was used daily for 4 weeks.nn

Posologie

posologieBy mouth: bark

posologie393 - 1600 mg

duration4 - weeks

formulationstandardized extract


Osteoarthritis
✪✪✪✪✪

Clinical research on willow bark extract for osteoarthritis remains contradictory today. Some preliminary clinical studies show that taking a standardized willow bark extract containing 120-240 mg of salicin per day for 2 to 6 weeks produces a moderate analgesic effect compared with placebo in patients with osteoarthritis, while improving swelling, tenderness and physical function. However, other research shows that taking a standardized willow bark extract at 240 mg of salicin per day for 6 weeks does not improve pain, stiffness or physical function compared with placebo in patients with osteoarthritis. Further studies will be needed to assess the effectiveness of willow bark extracts in treating osteoarthritis.

Posologie

posologieOral: bark

posologie393 - 1600 mg

duration6 - weeks

formulationstandardized extract


Rheumatoid arthritis
✪✪✪✪✪

In relation to its anti-inflammatory and analgesic properties, willow bark could be recommended for inflammatory rheumatic conditions. However, preliminary clinical research suggests that willow bark extract is not effective against rheumatoid arthritis. Further studies will be necessary to validate these results.

Posologie

posologieOral use: bark

posologie393 - 1600 mg

formulationstandardized extract


Properties


Analgesic

full-leaffull-leaffull-leaffull-leaf

When ingested, willow bark extracts inhibit the production of certain inflammatory substances (prostaglandins) via the cyclooxygenase (COX)-2 enzyme pathway, without directly affecting COX-1 or COX-2 enzymes. Salicin, converted to salicylic acid in the body, is responsible for this effect. Other components of willow bark may also play a role by inhibiting other inflammatory pathways and providing antioxidant effects, thereby contributing to the analgesic effect. Clinical studies have validated the effectiveness of these extracts for treating osteoarthritis and chronic low back pain.

Usages associés

Migraine, Flu, Low back pain, Joint pain, Common cold, Rheumatoid arthritis, Osteoarthritis

Anti-inflammatory

full-leaffull-leaffull-leafempty-leaf

Clinical studies have shown that willow bark extracts, particularly those standardized for salicin, have anti-inflammatory and analgesic properties. These extracts inhibit certain enzymes and inflammatory substances in the body, such as prostaglandins. In addition to salicin, other components of willow bark, such as flavonoids and polyphenols, also contribute to these effects. Tests in animal models have indicated that willow extract is at least as effective as aspirin at reducing inflammation, and may be gentler on the stomach.

Usages associés

Migraine, Flu, Low back pain, Joint pain, Common cold, Rheumatoid arthritis, Osteoarthritis

Antiplatelet/Anticoagulant

full-leaffull-leafempty-leafempty-leaf

White willow has antiplatelet properties due to salicin, a precursor of salicylic acid, but to a lesser degree than aspirin.


Safe dosage

Adults aged 18 years and older: 480 mg - 1200 mg (dry extract)

For use only by adults (dry extract estimated at 15% salicyline). - Herbal tea: 1 to 3 g of the crushed plant material in 150 ml of boiling water, infused 3 times a day. - Decoction: 4 g of the crushed plant material are added to a cup (200 ml) of water and boiled covered for 15 minutes. Let stand for 15 minutes, then strain. Drink after meals, 3 times a day, one glass of freshly prepared hot decoction. - Plant material powder: 260-500 mg 3-8 times a day. Take after meals. It is recommended to take it with a larger amount of hot water. - Dry aqueous extract (8-20:1): 600 mg twice a day - Dry aqueous extract (16-23:1): 480 mg twice a day - Tincture (1:5): 15-24 ml per day


Interactions

Médicaments

Acetazolamide: minor interaction

Willow bark contains salicin, a plant salicylate. Human case reports suggest that a combination of acetazolamide and salicylate increases plasma levels of unbound acetazolamide, as well as acetazolamide-related adverse effects. Theoretically, willow bark could lead to additive adverse effects associated with acetazolamide.

Antiplatelet agents/Anticoagulants: major interaction

Concurrent use could theoretically increase the risk of bleeding due to decreased platelet aggregation. Willow bark has antiplatelet effects, but less than aspirin. nnAvoid concurrent use with other anticoagulant and antiplatelet medications. Some of these medications include aspirin, clopidogrel, dalteparin, enoxaparin, heparin, ticlopidine, warfarin, and others.

Aspirin: moderate interaction

Willow bark contains salicin, a plant salicylate. Theoretically, willow bark could have an additive effect with other salicylate-containing medications such as aspirin.

Magnesium trisalicylate: minor interaction

Willow bark contains salicin, a plant salicylate. Theoretically, willow bark could have an additive effect with other salicylate-containing medications such as choline and magnesium trisalicylate.

Salsalate: moderate interaction

Willow bark contains salicin, a plant salicylate. Theoretically, willow bark could have an additive effect with other salicylate-containing medications such as salsalate.

Nonsteroidal anti-inflammatory drugs: moderate interaction

Concurrent use with salicylates and other NSAIDs is not recommended without medical advice.

Plantes ou autres actifs

Antiplatelet agents/Anticoagulant: low interaction

Salicin from white willow and anticoagulant supplements have additive effects. Avoid concurrent use as it could increase the risk of bleeding.

White willow: low interaction

Theoretically, concurrent use may potentiate salicylate effects and adverse effects.

White willow: low interaction

Theoretically, concurrent use may potentiate salicylate effects and adverse effects.


Precautions

Allergies: avoid

According to the precautionary principle, willow is not recommended for people with an individual hypersensitivity to acetylsalicylic derivatives (0.2% of the population).

Gastric ulcer: avoid

Contraindicated in cases of active gastroduodenal ulcer.


Contraindications

Children up to 18 years: prohibited

Use in children and adolescents under 18 years is contraindicated due to the risk of Reye's syndrome.

Pregnant women: prohibited

Use during the first and second trimesters of pregnancy and during breastfeeding is not recommended. Salicylates cross the placenta and are excreted in breast milk.

Breastfeeding women: prohibited

Use during the first and second trimesters of pregnancy and during breastfeeding is not recommended. Salicylates cross the placenta and are excreted in breast milk.

G6PD deficiency: prohibited

Glucose-6-phosphate dehydrogenase deficiency or favism.

Renal insufficiency: prohibited

Severe liver or kidney dysfunction.

Hepatic insufficiency: prohibited

Severe liver or kidney dysfunction.

Coagulation disorder: contraindicated

Risk of bleeding.nn

Reye syndrome: contraindicated

A history of Reye syndrome is a contraindication.nn